These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28689023)

  • 1. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps.
    Johdi NA; Mazlan L; Sagap I; Jamal R
    Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome.
    Stayoussef M; Weili X; Habel A; Barbirou M; Bedoui S; Attia A; Omrani Y; Zouari K; Maghrebi H; Almawi WY; Bouhaouala-Zahar B; Larbi A; Yacoubi-Loueslati B
    Cancer Immunol Immunother; 2024 Jul; 73(9):169. PubMed ID: 38954024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
    Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
    Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cytokine levels and the presence of colorectal cancer.
    Yamaguchi M; Okamura S; Yamaji T; Iwasaki M; Tsugane S; Shetty V; Koizumi T
    PLoS One; 2019; 14(3):e0213602. PubMed ID: 30883594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients.
    Pietrzyk Ł; Wdowiak P
    Adv Med Sci; 2019 Sep; 64(2):402-408. PubMed ID: 31352222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intake consumption of ginsenoside Rg3, profiling of selected cytokines, and development of rectal polyps.
    Xie J; Luo S; Mi H; Du Y; Bao G; Zhou J; Xi Y; Li C
    Cancer Manag Res; 2019; 11():4059-4064. PubMed ID: 31190981
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma.
    Henry CJ; Sedjo RL; Rozhok A; Salstrom J; Ahnen D; Levin TR; D'Agostino R; Haffner S; DeGregori J; Byers T
    BMC Cancer; 2015 Mar; 15():123. PubMed ID: 25884547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT).
    Jin YB; Zhang GY; Lin KR; Chen XP; Cui JH; Wang YJ; Luo W
    PLoS One; 2017; 12(2):e0172264. PubMed ID: 28207826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer.
    Lu Z; Zou J; Hu Y; Li S; Zhou T; Gong J; Li J; Zhang X; Zhou J; Lu M; Wang X; Peng Z; Qi C; Li Y; Li J; Li Y; Zou J; Du X; Zhang H; Shen L
    JAMA Netw Open; 2019 Jul; 2(7):e197621. PubMed ID: 31339548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
    BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an enzyme-linked immunosorbent assay for detection of CDCP1 shed from the cell surface and present in colorectal cancer serum specimens.
    Chen Y; Harrington BS; Lau KCN; Burke LJ; He Y; Iconomou M; Palmer JS; Meade B; Lumley JW; Hooper JD
    J Pharm Biomed Anal; 2017 May; 139():65-72. PubMed ID: 28279929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammatory factors promote the development of colorectal cancer].
    Guo Q; Shen S; Li X; Tang K; Zhou W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):646-9. PubMed ID: 21873790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients.
    Duan B; Bai J; Qiu J; Wang J; Tong C; Wang X; Miao J; Li Z; Li W; Yang J; Huang C
    EBioMedicine; 2018 Nov; 37():134-143. PubMed ID: 30361067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
    Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
    Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1.
    Heijmans-Antonissen C; Wesseldijk F; Munnikes RJ; Huygen FJ; van der Meijden P; Hop WC; Hooijkaas H; Zijlstra FJ
    Mediators Inflamm; 2006; 2006(1):28398. PubMed ID: 16864900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-based protein biomarker panel for the detection of colorectal cancer.
    Fung KY; Tabor B; Buckley MJ; Priebe IK; Purins L; Pompeia C; Brierley GV; Lockett T; Gibbs P; Tie J; McMurrick P; Moore J; Ruszkiewicz A; Nice E; Adams TE; Burgess A; Cosgrove LJ
    PLoS One; 2015; 10(3):e0120425. PubMed ID: 25793510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
    Ito H; Miki C
    Scand J Gastroenterol; 1999 Nov; 34(11):1139-43. PubMed ID: 10582766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma.
    Radosavljevic G; Ljujic B; Jovanovic I; Srzentic Z; Pavlovic S; Zdravkovic N; Milovanovic M; Bankovic D; Knezevic M; Acimovic LJ; Arsenijevic N
    Neoplasma; 2010; 57(2):135-44. PubMed ID: 20099977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer.
    Jiang H; Fu XG; Chen YT
    Genet Mol Res; 2015 May; 14(2):5519-26. PubMed ID: 26125749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.